Boonrit N., Klaidokchan N., Niyomdecha A., Noppamas J., Suknuntha K., Prasertsan P., Thaworncheep S., Ruanglertboon W., 2024. Development and Evaluation of a Prototype Mobile Application for Intravenous Drug Dose Calculation in Overweight and Obese Thai Children: Precision Dosing in Practice. Hospital Pharmacy 59(4): 453-459. (cited 0 times)

Boonrit N., Chaisawat K., Phueakong C., Nootong N., Ruanglertboon W., 2024. Exploring community pharmacists’ attitudes in Thailand towards ChatGPT usage: A pilot qualitative investigation. Digital Health 10 (cited 0 times)

Kidpun P., Ruanglertboon W., Chalongsuk R., 2022. State-of-the-art knowledge on the regulation of advanced therapy medicinal products. Personalized Medicine 19(3): 251-261. (cited 1 times)

Abuhelwa A.Y., Badaoui S., Yuen H.Y., McKinnon R.A., Ruanglertboon W., Shankaran K., Tuteja A., Sorich M.J., Hopkins A.M., 2022. A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology 89(4): 479-485. (cited 2 times)

Ruanglertboon W., Sorich M.J., Hopkins A.M., Rowland A., 2021. Mechanistic modelling identifies and addresses the risks of empiric concentration-guided sorafenib dosing. Pharmaceuticals 14(5) (cited 6 times)

Ruanglertboon W., Sorich M.J., Logan J.M., Rowland A., Hopkins A.M., 2020. The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib. Journal of Cancer Research and Clinical Oncology 146(10): 2693-2697. (cited 11 times)

Ruanglertboon W., Sorich M.J., Rowland A., Hopkins A.M., 2020. Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients. International Journal of Clinical Oncology 25(9): 1672-1677. (cited 7 times)

Ruanglertboon W., Kumarnsit E., Dej-Adisai S., Vongvatcharanon U., Udomuksorn W., 2019. The neuroprotective effect of nasturtium officinale on learning ability and density of parvalbumin neurons in the hippocampus of neurodegenerative-induced mice model. Sains Malaysiana 48(10): 2191-2199. (cited 1 times)

Rowland A., Ruanglertboon W., van Dyk M., Wijayakumara D., Wood L.S., Meech R., Mackenzie P.I., Rodrigues A.D., Marshall J.C., Sorich M.J., 2019. Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure. British Journal of Clinical Pharmacology 85(1): 216-226. (cited 65 times)